Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 23;15(1):e34096.
doi: 10.7759/cureus.34096. eCollection 2023 Jan.

False-Positive Human Immunodeficiency Virus Results in COVID-19 Patients

Narek Hakobyan  1 , Ruchi Yadav  1 , Khaled Abaza  2 , Adam Friedman  3
Affiliations
Case Reports

False-Positive Human Immunodeficiency Virus Results in COVID-19 Patients

Narek Hakobyan et al. Cureus. .

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which causes coronavirus disease 2019 (COVID-19) disease, was first described in 2019 and became a pandemic in 2020. Although it is possible for two viruses to co-infect together, a rarer phenomenon of false-positive results due to cross-reactivity between viruses is also possible. Herein, we present two cases of the false-positive human immunodeficiency virus (HIV) results in those infected with COVID-19. Both patients were screened for HIV and were initially found to be positive with the fourth-generation test. A subsequent blood test revealed no viral load, and an enzyme-linked immunosorbent assays (ELISA) test indicated no reactivity to HIV, thus the false initial screening test. SARS-CoV-2 is an enveloped RNA virus with its outer surface containing a spike-like glycoprotein, which allows it to recognize host cells and invade. HIV-1 gp41 and SARS-CoV-2 share several structural sequences and motifs. These similarities could explain cross-reactivity and false-positive results when screening for HIV in the presence of COVID. The presence of HIV must be confirmed through more specific laboratory tests such as ELISA.

Keywords: covid-19; enzyme linked immunosorbent assay (elisa); fourth generation hiv screening test; human immunodeficiency virus infection; sars-cov-2.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Calcification of bilateral basal ganglia
Figure 2
Figure 2. Bilateral consolidations and atelectasis of the lower lung fields
Figure 3
Figure 3. The enzyme-linked immunosorbent assay (ELISA) technique that involves the use of plate-based assay for the detection and quantification of soluble substances such as antibodies
See this image and copyright information in PMC

References

    1. A severe refractory COVID-19 patient responding to convalescent plasma; a case series. Abdullah HM, Hama-Ali HH, Ahmed SN, et al. Ann Med Surg (Lond) 2020;56:125–127. - PMC - PubMed
    1. False-positive HIV in a patient with SARS-CoV-2 infection; a case report. Salih RQ, Salih GA, Abdulla BA, Ahmed AD, Mohammed HR, Kakamad FH, Salih AM. Ann Med Surg (Lond) 2021;71:103027. - PMC - PubMed
    1. Post covid-19 invasive pulmonary Aspergillosis: A case report. Kakamad FH, Mahmood SO, Rahim HM, et al. Int J Surg Case Rep. 2021;82:105865. - PMC - PubMed
    1. Post COVID-19 transverse myelitis; a case report with review of literature. Ahmad SA, Salih KH, Ahmed SF, et al. Ann Med Surg (Lond) 2021;69:102749. - PMC - PubMed
    1. Potential antigenic cross-reactivity between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue viruses. Lustig Y, Keler S, Kolodny R, et al. Clin Infect Dis. 2021;73:0–9. - PMC - PubMed

Publication types

LinkOut - more resources